Loading data for INM — first visit, this takes a few seconds.
InMed Pharmaceuticals Inc. (INM)
NasdaqCM: INM
· Real-Time Price · USD
1.35
+0.03 (2.27%)
At close: Sep 02, 2026, 3:58 PM
1.33
-1.48%
After-hours: 6:39 PM
The price, the headline numbers and the latest news, in one place.
InMed Pharmaceuticals Inc. (INM) Stock Price, Analysis & Data
2.27% (1D)
| Bid | 0.97 |
| Market Cap | 7.21M |
| Revenue (ttm) | 4.94M |
| Net Income (ttm) | -7.84M |
| 0.98 | |
| -1.52 | |
| n/a | |
| -0.22 | |
| P/B (ttm) | 0.65 |
| P/S (ttm) | 1.46 |
| Earnings Date | Sep 23, 2026 |
| Ask | 1.72 |
| Volume | 19,870 |
| Avg. Volume (20D) | 927,753 |
| Open | 1.35 |
| Previous Close | 1.32 |
| Day's Range | 1.33 - 1.40 |
| 52-Week Range | 0.57 - 2.50 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About INM
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabino...
Sector Healthcare
IPO Date May 5, 2014
Employees 13
Stock Exchange NasdaqCM
Ticker Symbol INM
Website https://www.inmedpharma.com
Financial Performance
In 2025, InMed Pharmaceuticals's revenue was 4.94M, an increase of 7.5% compared to the previous year's 4.6M. Earnings were -8.16M, an increase of 6.34%.
Financial StatementsEarnings Surprise
InMed Pharmaceuticals has released their quarterly earnings on Nov 15, 2022:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -107.86 exceeds estimates by 0.64, with 30.63% YoY growth.
InMed Pharmaceuticals Inc. is scheduled to release its earnings on Sep 23, 2026, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
